Elligo is proud to announce that we’re being recognized as one of Austin’s most innovative homegrown companies on the 2019 Austin A-List! We were recognized for our work to provide all patients with access to clinical research as a care option by reaching out to physicians and patients who otherwise would not be able to participate in clinical research. Through our novel IntElligo Research Stack™ clinical technology and Goes Direct® approach, we accelerate the development of pharmaceutical, biotechnology, medical device, and diagnostic products. See the full 2019 Austin A-List at https://www.austinchamber.com/blog/austin-chamber-announces-most-innovation-homegrown-companies-of-2019.